CHU Brabois Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00408473
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Brabois Hospital, Nancy, France | CHU Brabois, 54511 Vandoeuvre les Nancy | CHU Brabois, avenue de Bourgogne, 54511 Vandoeuvre-les-Nancy. FRANCE | CHU Brabois -Vandoeuvre les Nancy -France | Pr. Nicolas GIRERD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Lymphoma (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 9